Yutong Liu1, Monica Sathyanesan2,3, and Samuel S Newton2,3
1Radiology, University of Nebraska Medical Center, Omaha, NE, United States, 2Basic Biomedical Sciences, University of South Dakota, Vermillion, SD, United States, 3Sioux Falls VA HealthCare System, Sioux Falls, SD, United States
Synopsis
In vivo MRI was used to detect and
measure the brain hemodynamic action of carbamoylated erythropoietin (Cepo) in mice. Brain
perfusion was measured using dynamic susceptibility contrast MRI, and BBB permeability
was detected by pre- and post-contrast T1 mapping. It was found that Cepo caused increased cerebral blood flow and volume. Consistent
pre- and post-contrast T1 values indicated no gadolinium leakage from vascular
system to brain tissue. In summary, chronic Cepo treatment induced increased
brain perfusion and this can be detected using in vivo MRI.
INTRODUCTION
Carbamoylated
erythropoietin (Cepo) - a chemically engineered erythropoietin (Epo) - is
non-erythropoietic but reproduces Epo’s neurotrophic and behavioral actions in
mice and rats. Previous studies have shown Epo increases angiogenesis and
restores cerebral blood flow after focal ischemia in mice1. This
study is to noninvasively and quantitatively measure the blood flow increase by
Cepo using MRI. The aim of the study is to test the hypothesis that
carbamoylated erythropoietin (Cepo) induces increased brain blood flow.METHODS
Both
acute and chronic effects of Cepo were tested. The acute group (male Balb/c
mice, n = 6) was treated with i.p. injection of 40 mg/kg
Cepo, and scanned after 3 hours. The chronic group (n = 6) was injected with 5
doses of Cepo (i.p., 40 ug/kg/day), and scanned after 24 hours of the last
dose. Two control groups were treated with acute and chronic PBS injections,
respectively. The mice were first scanned with RARE VTR for pre-contrast T1
mapping. T2*-weighted MRI was performed using EPI GRE with TR = 1 s and scan
time = 60 s. Gadolinium was injected through tail vein at 10 s with a dose =
0.1 mmol/kg followed by post-contrast T1 mapping. Relative Cerebral blood
volume (rCBV), relative cerebral blood flow (rCBF), mean transit time (MTT) and
time to peak (TPP) maps were generated using DSCoMAN2,3. K2 maps were also
generated. T1 maps were calculated using an in-house fitting program4.RESULTS
Increased perfusion was found in mice with
chronic Cepo injection compared to controls. Figure 1B and E shows the rCBV
maps of a chronic Cepo mouse and a control. Relative CBF maps are shown in
Figure 1C and F for the Cepo and control mice, respectively. T2*-weighted EPI
images are included in Figure 1A and D as anatomical references. Higher rCBV
and rCBF can be observed on hippocampus and striatum in the Cepo mouse than in
the control. The ROI analysis found significant rCBV increase in chronic Cepo
mice on hippocampus (p = 0.023) and striatum (p = 0.012). Relative CBF showed
the trend of increase on hippocampus in Cepo mice (p = 0.061) and significant
increase on striatum (p = 0.044). No significant difference on MTT and TTP was
found. The heat maps of T1 on hippocampus and striatum are superimposed on an
anatomical image and shown in Figure 2. The ROI analysis found no significant
difference between pre- and post-contrast T1 on hippocampus (pre-contrast T1 =
2103 ± 84 ms vs post-contrast T1 = 2010 ± 79 ms) and striatum (pre-contrast T1 = 1790 ± 69 ms vs post-contrast T1 = 1814 ± 41 ms). No significant difference was found between
pre- and post-contrast T1 values in both Cepo mice and controls.DISCUSSION
Our study demonstrated in vivo MRI is able to
detect and measure increased brain perfusion induced by chronic Cepo treatment.
Cepo caused increased cerebral blood flow and volume, and the time course of
gadolinium passage (as shown by MTT and TTP) in brain was not changed. Consistent
pre- and post-contrast T1 values indicated no gadolinium leakage from vascular
system to brain tissue. K2 maps also confirmed intact BBB. We did not find
significant changes in perfusion in acute treated mice. In summary, chronic
Cepo treatment induced increased brain perfusion and this can be detected using
in vivo MRI.Acknowledgements
This study is partially supported by NIH RO1 MH106640 (SN) and Nebraska Research Initiative (YL).
References
1.
Li Y, Lu Z, Keogh
CL, Yu SP, Wei L. Erythropoietin-induced neurovascular protection,
angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.
J Cereb Blood Flow Metab. 2007 27:1043-1054.
2.
1.https://sites.duke.edu/dblab/dscoman/
3. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent
extravasation significantly correlate with glioma tumor grade, whereas
uncorrected maps do not. AJNR Am J Neuroradiol. 2006 Apr;27(4):859-67
4. Bade AN, Gendelman HE, Boska MD, Liu Y. MEMRI is a biomarker defining nicotine-specific neuronal responses in subregions of the rodent brain. Am J Transl Res. 2017 Feb 15;9(2):601-610